11/21
05:31 am
rvph
Reviva Pharmaceuticals (NASDAQ:RVPH) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Medium
Report
Reviva Pharmaceuticals (NASDAQ:RVPH) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
9/29
08:05 am
rvph
Reviva Pharmaceuticals (NASDAQ:RVPH) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $2.00 price target on the stock.
Low
Report
Reviva Pharmaceuticals (NASDAQ:RVPH) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $2.00 price target on the stock.
9/29
07:19 am
rvph
Rating for RVPH
Low
Report
Rating for RVPH
9/29
06:05 am
rvph
Reviva Pharmaceuticals initiated with a Buy at Chardan
Low
Report
Reviva Pharmaceuticals initiated with a Buy at Chardan
9/15
08:58 am
rvph
Rating for RVPH
Medium
Report
Rating for RVPH
9/15
08:58 am
rvph
Rating for RVPH
Medium
Report
Rating for RVPH